Season 2 of our podcast “Micro-dosing with Zeifmans” was a real trip. Pulling knowledge from industry expert guests, we examined the industry as it currently is, and painted a vivid ...

Regulatory support will always trail behind public acceptance and one prominent example of this is the US’s outdated Internal Revenue Code Section 280E as it relates to the cannabis industry.  In a long well-publicized battle, Oakland-based Harborside Inc. (listed on the Canadian Securities Exchange and operator ...

Employers in Canada’s emerging industries like cannabis, psychedelics, and agritech are concerned about how upcoming changes to the taxation of stock options will impact their ability to recruit top talent. ...

Have you stopped to poke your head up yet? For many Canadian businesses, the last year has felt like competing in an Olympic-level hurdles race. We’ve weathered one challenge after ...

It’s been predicted that the plant-based food market will be worth an estimated $74.2 billion[1] by 2027. We’re not talking about your mother’s tofu anymore – plant protein foods come ...

It’s no secret that the cannabis industry has faced some challenges since legalization. Though regulations are changing in favour of the industry’s growth, residue from past taboos and fumbled launches ...

As we’ve spoken about in previous blog posts, the psychedelics industry has been rapidly expanding to become a key component in the treatment of a host of mental illnesses. With ...

Innovations in psychedelics are poised to disrupt the pharmaceutical industry, and the Zeifmans Cannabis and Psychedelics Team has been hard at work in the space and is here to demystify ...

Research is proving the impressive efficacy of psychedelics in treating conditions like anxiety, depression, and opioid addiction. Psychedelic substances like MDMA, LSD, ketamine, and most notably psilocybin (magic mushrooms) have ...